Signet Financial Management, LLC Mannkind Corp Transaction History

Signet Financial Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.62 - $4.45 $65 - $111	-25 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$4.05 - $5.37 $101 - $134	25 New	25 $0
Q4 2018 Feb 14, 2019	SELL	$1.02 - $2.05 $25 - $51	-25 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.01 - $2.19 $164 - $356	-163 Reduced 86.7%	25 $0
Q1 2018 May 15, 2018	BUY	$2.28 - $3.8 $428 - $714	188 New	188 $0

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.69B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Signet Financial Management, LLC with notifications on news.